Suchergebnisse - "Zeissig, Mara N"

PubPharm (8)

1

Expression of the chemokine receptor CCR1 decreases sensitivity to bortezomib in multiple myeloma cell lines

enthalten in: Leukemia research | 2024

von Zeissig, M. | Hewett, D. | Mrozik, K. | +7

2

Next batter up! Targeting cancers with KRAS-G12D mutations

enthalten in: Trends in cancer | 2023

von Zeissig, M. | Ashwood, L. | Kondrashova, O. | +1

3

PTP1B is an intracellular checkpoint that limits T cell and CAR T cell anti-tumor immunity

enthalten in: bioRxiv.org | 2023

von Wiede, F. | Lu, K. | Du, X. | +12

4

PTP1B Is an Intracellular Checkpoint that Limits T-cell and CAR T-cell Antitumor Immunity

enthalten in: Cancer discovery | 2022

von Wiede, F. | Lu, K. | Du, X. | +12

CommentIn: Nat Cell Biol. 2022 Jan;24(1):1. - PMID 35027737

5

PTPN2 elicits cell autonomous and non-cell autonomous effects on antitumor immunity in triple-negative breast cancer

enthalten in: Science advances | 2022

von Goh, P. | Wiede, F. | Zeissig, M. | +10

6

Expression of the chemokine receptor CCR1 promotes the dissemination of multiple myeloma plasma cells in vivo

enthalten in: Haematologica | 2021

von Zeissig, M. | Hewett, D. | Panagopoulos, V. | +5

7

Tumour Dissemination in Multiple Myeloma Disease Progression and Relapse : A Potential Therapeutic Target in High-Risk Myeloma

enthalten in: Cancers | 2020

von Zeissig, M. | Zannettino, A. | Vandyke, K.

8

HIF-2α Promotes Dissemination of Plasma Cells in Multiple Myeloma by Regulating CXCL12/CXCR4 and CCR1

enthalten in: Cancer research | 2017

von Vandyke, K. | Zeissig, M. | Hewett, D. | +9

1
[1]